Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
Salivary glands sarcoidosis
Operative Techniques in Otolaryngology-Head and Neck Surgery, 05/22/09
Rao V et al. - There are no FDA approved therapies for sarcoidosis. Corticosteroids remain the standard of care. Corticosteroid sparing agents may be used in patients with progressive disease. The use of tumor necrosis factor inhibitors may be effective in refractory cases.
Related Articles
The role of EBUS-TBNA for the diagnosis of sarcoidosis – comparisons with other bronchoscopic diagnostic modalities
Respiratory Medicine, 11/18/09
Relevance Score: 89%
Serum Amyloid A Regulates Granulomatous Inflammation in Sarcoidosis through Toll-like Receptor-2
American Journal of Respiratory and Critical Care Medicine, 11/13/09
Relevance Score: 89%
The value of endoscopic ultrasound after bronchoscopy to diagnose thoracic sarcoidosis
European Respiratory Journal, 11/11/09
Relevance Score: 89%
Sarcoidosis-Associated Fibrosing Mediastinitis with Resultant Pulmonary Hypertension: A Case Report and Review of the Literature
Respiration, 10/06/09
Relevance Score: 88%
Sarcoidosis of the submandibular gland: A systematic review
American Journal of Otolaryngology, 10/15/09
Relevance Score: 87%
Today in Sarcoidosis...keeping you current
Receive free subspecialty "5-minute updates" via email
Functional analysis of dendritic cell–T cell interaction in sarcoidosis
Clinical and Experimental Immunology, 12/03/09
Acute-onset sarcoidosis with polyarthralgia and hilar lymphadenopathy
Modern Rheumatology, 12/01/09
Prevalence of sarcoidosis in Switzerland is associated with environmental factors
European Respiratory Journal , 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


